Skip to main content
logo
Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.605
-0.055 (-1.50%)
At close: Aug 26, 2026, 4:00 PM EDT
3.495
-0.110 (-3.05%)
Pre-market: Aug 27, 2026, 4:00 AM EDT

Anixa Biosciences Income Statement

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Revenue
---0.21-0.51
Revenue Growth
------
Cost of Revenue
---0.16-0.39
Gross Profit
---0.05-0.13
Selling, General & Admin
6.126.637.446.297.177.07
Research & Development
4.565.076.44.776.76.19
Operating Expenses
10.6811.713.8311.0613.8813.26
Operating Income
-10.68-11.7-13.83-11.01-13.88-13.14
Interest & Investment Income
0.550.671.131.080.10
EBT Excluding Unusual Items
-10.12-11.03-12.7-9.93-13.77-13.13
Gain (Loss) on Sale of Assets
-----0.01
Pretax Income
-10.12-11.03-12.7-9.93-13.77-13.13
Earnings From Continuing Operations
-10.12-11.03-12.7-9.93-13.77-13.13
Minority Interest in Earnings
0.090.10.140.120.180.17
Net Income
-10.03-10.93-12.55-9.81-13.6-12.95
Net Income to Common
-10.03-10.93-12.55-9.81-13.6-12.95
Net Income Growth
------
Shares Outstanding (Basic)
333232313029
Shares Outstanding (Diluted)
333232313029
Shares Change
2.80%1.74%2.96%1.99%6.28%28.57%
EPS (Basic)
-0.30-0.34-0.39-0.32-0.45-0.45
EPS (Diluted)
-0.30-0.34-0.39-0.32-0.45-0.45
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Free Cash Flow
-7.12-7.17-7.34-6.21-6.49-4.94
Free Cash Flow Per Share
-0.21-0.22-0.23-0.20-0.21-0.17
Gross Margin
---23.33%-24.80%
Operating Margin
----5243.33%--2565.63%
Profit Margin
----4671.91%--2530.08%
Free Cash Flow Margin
----2956.67%--964.45%
EBITDA
------13.1
D&A For EBITDA
-----0.04
EBIT
-10.68-11.7-13.83-11.01-13.88-13.14
SEC Filings: 10-K · 10-Q